Last update 20 Feb 2025
Leshan Sanjiu Long March Pharmaceuticals Co. Ltd.

Leshan Sanjiu Long March Pharmaceuticals Co. Ltd.

Private Company | Subsidiary Company|
1993|
Sichuan Sheng, China
|
www.longmarch.com.cn

Overview

Tags

Infectious Diseases
Other Diseases
Cardiovascular Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases6
Nervous System Diseases2
Immune System Diseases2
Hemic and Lymphatic Diseases1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug6
Top 5 TargetCount
PBPs(Bacterial penicillin-binding protein)2
DprE1(FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase)1
30S subunit(30S ribosomal subunit)1
rpoB(DNA-directed RNA polymerase beta chain)1
RNAP(Bacterial DNA-directed RNA polymerase)1

Related

6
Drugs associated with Leshan Sanjiu Long March Pharmaceuticals Co. Ltd.
Rifapentine
Target
rpoB
Mechanism
rpoB inhibitors
Active Org.
The Johns Hopkins UniversityThe Johns Hopkins University [+3]
Originator Org.
SanofiSanofi
Active Indication
Pulmonary Tuberculosis [+4]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date01 Jan 1994
Cefotaxime Sodium
Target
PBPs
Mechanism
PBPs inhibitors [+1]
Active Org.
Pfizer Australia Pty Ltd.Pfizer Australia Pty Ltd. [+5]
Originator Org.
Sanofi, Inc.
Active Indication
Infectious Diseases [+16]
Inactive Indication
Bacteremia [+3]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.-
First Approval Date01 Jan 1980
Cephalothin Sodium
Target
PBPs
Mechanism
PBPs inhibitors [+1]
Active Org.
Leshan Sanjiu Long March Pharmaceuticals Co. Ltd.Leshan Sanjiu Long March Pharmaceuticals Co. Ltd. [+1]
Originator Org.
Eli Lilly & Co.Eli Lilly & Co.
Active Indication
Bacterial Infections [+8]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date18 Dec 1974
100 Clinical Results associated with Leshan Sanjiu Long March Pharmaceuticals Co. Ltd.
Login to view more data
0 Patents (Medical) associated with Leshan Sanjiu Long March Pharmaceuticals Co. Ltd.
Login to view more data
100 Deals associated with Leshan Sanjiu Long March Pharmaceuticals Co. Ltd.
Login to view more data
100 Translational Medicine associated with Leshan Sanjiu Long March Pharmaceuticals Co. Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
5
Approved
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free